Icell Kealex Therapeutics

Developing T cell engager-armed oncolytic virus for the treatment of solid tumours.

placeHouston, Texas, United States calendar_todayFounded 2015 language icellkealex.com

Innovation

2 patent families — focus: Chemistry & metallurgy; filing pace slowing. Cited 19 times.

YearFilings
20201
20212

Investor mix

2 investors on record.

Investor typeCountShare
Accelerator & incubator150%
Other / undisclosed150%
Coming soon